Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;374(5-6):413-28.
doi: 10.1007/s00210-007-0132-3. Epub 2007 Jan 23.

Regulation and functional roles of sphingosine kinases

Affiliations
Review

Regulation and functional roles of sphingosine kinases

Regina Alemany et al. Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb.

Abstract

Sphingosine kinases (SphKs) catalyze the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). Together with other sphingolipid metabolizing enzymes, SphKs regulate the balance of the lipid mediators, ceramide, sphingosine, and S1P. The ubiquitous mediator S1P regulates cellular functions such as proliferation and survival, cytoskeleton architecture and Ca(2+) homoeostasis, migration, and adhesion by activating specific high-affinity G-protein-coupled receptors or by acting intracellularly. In mammals, two isoforms of SphK have been identified. They are activated by G-protein-coupled receptors, receptor tyrosine kinases, immunoglobulin receptors, cytokines, and other stimuli. The molecular mechanisms by which SphK1 and SphK2 are specifically regulated are complex and only partially understood. Although SphK1 and SphK2 appear to have opposing roles, promoting cell growth and apoptosis, respectively, they can obviously also substitute for each other, as mice deficient in either SphK1 or SphK2 had no obvious abnormalities, whereas double-knockout animals were embryonic lethal. In this review, our understanding of structure, regulation, and functional roles of SphKs is updated and discussed with regard to their implication in pathophysiological and disease states.

PubMed Disclaimer

References

    1. Mol Endocrinol. 2003 Oct;17(10):2002-12 - PubMed
    1. Biochim Biophys Acta. 2007 Apr;1768(4):923-40 - PubMed
    1. Annu Rev Biochem. 2004;73:321-54 - PubMed
    1. Biochem J. 2000 Sep 1;350 Pt 2:429-41 - PubMed
    1. J Biol Chem. 2006 Apr 28;281(17):11693-701 - PubMed

MeSH terms

LinkOut - more resources